Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease

Status:
Completed

Trial end date:
2003-06-01

Target enrollment:

Participant gender:

Study of an investigational medication for the treatment of Alzheimer's Disease in patients who are not taking Aricept, Reminyl, Exelon.

Phase 2

Eli Lilly and Company